Molecular Diagnostics Market Worth USD 43.69 Billion by 2032 with 7.14% CAGR
Molecular Diagnostics Market to Surpass USD 43.69 Billion by 2032, Driven by Decentralized Point-of-Care Testing, Oncology Advancements, and AI Integration The global healthcare landscape is witnessing a profound paradigm shift from retrospective, generalized medicine toward predictive, precise, and highly personalized intervention. At the absolute epicenter of this evolution stands the molecular diagnostics industry. By examining clinical anomalies at the foundational genetic, proteomic, and cellular levels, molecular diagnostics has evolved from a specialized academic luxury into an absolute prerequisite for modern clinical workflows. Driven by the unrelenting prevalence of infectious illnesses, complex oncological mutations, and genetic abnormalities, the global market is undergoing an era of rapid technological maturation. According to a comprehensive industry study published by Maximize Market Research, the global Molecular Diagnostics Market was valued at USD 26.96 Billion...